Compare · MDLN vs NVST
MDLN vs NVST
Side-by-side comparison of Medline Inc. (MDLN) and Envista Holdings Corporation (NVST): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and NVST operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $48.08B, about 12.7x NVST ($3.77B).
- MDLN has been more active in the news (7 items in the past 4 weeks vs 2 for NVST).
- Both have 25 recent analyst ratings on file.
- Company
- Medline Inc.
- Envista Holdings Corporation
- Price
- $35.95-1.74%
- $22.91-2.51%
- Market cap
- $48.08B
- $3.77B
- 1M return
- -
- -3.27%
- 1Y return
- -
- +16.15%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NYSE
- IPO
- 2025
- 2019
- News (4w)
- 7
- 2
- Recent ratings
- 25
- 25
Envista Holdings Corporation
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, and markets dental products in the United States and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment provides dental implant systems, guided surgery systems, biomaterials, prefabricated and custom-built prosthetics, and dental eye loupes to oral surgeons, prosthodontists, and periodontists under the brands, including Nobel Biocare, Alpha Bio Tec, Implant Direct, Logon, Nobel Procera, and Orascoptic; and brackets and wires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products under the Damon, Ormco, Insignia, AOA, and Spark brands. This segment also offers software packages used for the treatment planning of dental implants and prosthetics. The company's Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; handpieces and associated consumables; treatment units and other dental practice equipment; endodontic systems and related consumables; and restorative materials and instruments, rotary burs, impression materials, bonding agents and cements, and infection prevention products. This segment offers its products under the Dexis, Gendex, i-CAT, KaVo, Kerr, Metrex, Sybron Endo, Total Care, and Pentron brands to dental offices, clinics, and hospitals. The company was incorporated in 2018 and is headquartered in Brea, California.
Latest MDLN
- SEC Form 8-K filed by Medline Inc.
- Medline to build Midwestern network with new 800,000-square-foot facility in Van Buren Township, Mich.
- SEC Form 4 filed by Medline Inc.
- Medline launches enhanced TrackPoint™ to simplify inventory management for post-acute care
- SEC Form 4 filed by Medline Inc.
- MEDLINE INC. MDLN INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 12.8% Share Drop
- Medline to report third quarter 2026 results on November 4, 2026
- INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Medline Inc. to Contact Law Firm
- Medline announces participation in the Morgan Stanley 24th Annual Global Healthcare Conference
- SEC Form 4 filed by Chief Executive Officer Boyle James M
Latest NVST
- Envista downgraded by Robert W. Baird with a new price target
- Envista Schedules Third Quarter 2026 Earnings Call
- Envista Holdings Corporation filed SEC Form 8-K: Regulation FD Disclosure
- Envista Announces Participation in Baird 2026 Global Healthcare Conference
- Envista upgraded by Analyst with a new price target
- President, Orthodontics Acurio Veronica covered exercise/tax liability with 7,710 shares, decreasing direct ownership by 14% to 48,806 units (SEC Form 4) (tax withholding)
- President, Diagnostics Befidi Robert covered exercise/tax liability with 5,147 shares, decreasing direct ownership by 10% to 45,785 units (SEC Form 4) (withholding tax)
- Chief Financial Officer Hammes Eric D. covered exercise/tax liability with 10,885 shares, decreasing direct ownership by 10% to 99,913 units (SEC Form 4) (tax liability)
- President, Nobel Biocare Nilsson Stefan covered exercise/tax liability with 804 shares, decreasing direct ownership by 1% to 61,560 units (SEC Form 4) (withholding tax)
- SVP, Strategy & Bus. Dev. Reis Mischa sold $220,000 worth of shares (8,000 units at $27.50) as part of a pre-agreed trading plan, decreasing direct ownership by 23% to 27,321 units (SEC Form 4)